The unintended consequences of cervical screening: Distress in women undergoing cytologic surveillance

Journal of Lower Genital Tract Disease

Volumn 18, Issue 2, 2014, Pages 142-150

  Sharp, Linda ^a   Cotton, Seonaidh ^b   Cruickshank, Margaret ^b   Gray, Nicola M ^b   Harrild, Kirsten ^b   Smart, Louise ^c   Walker, Leslie G ^d   Little, Julian ^e  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

atypical squamous cells of undetermined significance; cervical screening; distress; follow up

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ANXIETY; ARTICLE; COLPOSCOPY; DEMOGRAPHY; DISTRESS SYNDROME; DYSKARYOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; IMPACT OF EVENTS SCALE; PAIN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PSYCHOLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; ANXIETY; CYTOLOGICAL TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; YOUNG ADULT;

EID: 84897581779     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31829c97d8     Document Type: Article

References (44)

1. CervicalCheck. The National Cervical Screening Programme. Programme Report, 1 September 2009 Y 31 August 2010. Dublin, Ireland: National Cancer Screening Service/ National Cancer Control Programme; 2011.
2. ISD Scotland. Cervical Screening. Annual Workload Data. Up to 31stMarch 2010. Available at: http://isd.scot.nhs.uk/ isd/1673.html. Accessed December 7, 2012.
3. Australian Institute of Health and Welfare. Cervical Screening in Australia 2008-2009. Cancer Series Number 61. Canberra, Australia: AIHW; 2011.
4. National Health and Medical Research Council. Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women With Screen Detected Abnormalities. Canberra, Australia: NHMRC; 2005.
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 ASCCP-Sponsored Consensus Conference. 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Screening Tests. J Low Genit Tract Dis 2007;11:201-22.
6. NHS Cervical Screening Programme. Colposcopy and Programme Management. Luesley D, Leeson S, eds. Guidelines for the NHS Cervical Screening Programme. 2nd ed. Sheffield, UK: NHSCSP; 2010.
7. Murphy J, Kennedy E, Dunn S, Fung Kee Fung M, Gzik D, McLachlin CM, et al. Cervical Screening. Program in Evidence-Based Care Evidence-based Series No. 15-9. Toronto, Ontario: Cancer Care Ontario; 2011.
8. Posner T, Vessey M. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988;95:729-32.
9. Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG 2002;109:364-8.
10. Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med 1995;24:610-6.
11. Jones MH, Singer A, Jenkins D. The mildly abnormal cervical smear: patient anxiety and choice of management. J Royal Soc Med 1996;89:257-60.
12. Kitchener HC, Burns S, Nelson L, Myers AJ, Fletcher I, Desai M, et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. BJOG 2004;111:63-70.
13. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6 month follow-up. Br J Cancer 2005; 92:990-4.
14. McCaffery KJ, Irwig L, Turner R, Chan SF,Macaskill P, Lewicka M, et al. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ 2010;340: b4491.
15. Cotton SC, Sharp L, Little J, Duncan I, Alexander L, Cruickshank ME, et al. The TOMBOLA Group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemp Clin Trials 2006;27:449-71.
16. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009;339:b2546.
17. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, NY: Springer-Verlag; 1996.
18. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41: 209-18.
19. Sundin EC, Horowitz MJ. Impact of Event Scale: psychometric properties. Br J Psychiatry 2002;180:205-9.
20. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
21. Wallston KA,Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr 1978;6:160-70.
22. Gray NM, Sharp L, Cotton SC, Avis M, Phillips Z, Russell I, et al. Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) trial. Qual Life Res 2005;14:1153-62.
23. Cotton S, Sharp L, Cochran C, Gray N, Cruickshank M, Smart L, et al. After-effects reported by women having follow-up cervical cytology tests in primary care: a cohort study within the TOMBOLA trial. Br J Gen Pract 2011; 61:e333-9.
24. Salvesen KA, Oyen L, Schmidt N, Malt UF, Eik-Nes SH. Comparison of long-term psychological responses of women after pregnancy termination due to fetal anomalies and after perinatal loss. Ultrasound Obstet Gynecol 1997;9:80-5.
25. Broen AN, Moum T, Bodtker AS, Ekeberg O. The course of mental health after miscarriage and induced abortion: a longitudinal, five-year follow-up study. BMC Med 2005;3:18.
26. HosmerDW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley; 1989.
27. Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, et al. on behalf of the TOMBOLA Group. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer 2006;94:1253-62.
28. Orbell S, Hagger M, Brown V, Tidy J. Appraisal theory and emotional sequelae of first visit to colposcopy following an abnormal cervical screening result. Br J Health Psychol 2004;9:533-55.
29. Tiersma ES, van der Lee ML, Peters AAW, Visser AP, Fleuren GJ, Garssen B, et al. Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study. Gynecol Oncol 2004;92:603-10.
30. Galaal KA, Deane K, Sangal S, Lopes AD. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev. 2007;CD006013.
31. Sharp L, Cotton S, Carsin A, Gray N, Thornton A, Cruickshank M, et al. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psychooncol 2013;22:368-80.
32. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, ProkopM, de Koning HJ, et al. Short-term healthrelated quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34.
33. Kruijshaar ME, Kerkhof M, Siersema PD, Steyerberg EW, Homs MY, Essink-Bot ML, CYBAR Study Group. The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy 2006;38:873-8.
34. O'Neill SM, Rubinstein WS, Sener SF, Weissman SM, Newlin AC, West DK, et al. Psychological impact of recall in high-risk breastMRI screening. Br Cancer Res Treat 2009;115: 365-71.
35. Shiloh S, Koehly L, Jenkins J, Martin J, Hadley D. Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psychooncol 2008;17:746-55.
36. Craig KJ, Brown KJ, Baum A. Environmental factors in the etiology of anxiety. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. American College of Neuropsychopharmacology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
37. French DP, Maissi E, Marteau TM. Psychological costs of inadequate cervical smear test results. BJC 2004;91:1887-92.
38. Sharp L, Cotton S, Thornton A, Gray N, Whynes D, Smart L, et al., on behalf of the TOMBOLA Group. Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial. Cytopathol 2012;23:150-60.
39. NHS Cervical Screening Programme. HPV triage and test of cure protocol, 2011. Available at: http://www.cancerscreening. nhs.uk/cervical/hpv-triage-test- of-cure-flowchart.pdf. Accessed December 7, 2012.
40. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Lower Genit Tract Dis 2012;16:175-204.
41. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillovirus testing in women with borderline or mildly dyskaryotic cervical smear test result: cross-sectional questionnaire study. BMJ 2004;328: 1293-6.
42. Sundin EC, Horowitz MJ. Horowitz's Impact of Event Scale evaluation of 20 years of use. Psychosom Med 2003; 65:870-6.
43. McDonald TW, Neutens JJ, Fischer LM, Jessee D. Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image. Gynecol Oncol 1989;34:345-9.
44. Largo-Janssen T, Schijf C. What do women think about abnormal smear test results? A qualitative interview study. J Psychosom Obstet Gynecol 2005;26:141-5.